Jose-Luis E Velazquez-Cecena MD
Adult Congenital Heart Disease, Non-Invasive Cardiology
Physician
Join to View Full Profile
9380 SW 150th StreetSte. 295Miami, FL 33176
Phone+1 305-256-5018
Dr. Velazquez-Cecena is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Chicago Medical School/Rosalind Franklin University of Medicine & ScienceFellowship, Cardiovascular Disease, 2005 - 2008
Rush University Medical CenterFellowship, Critical Care Medicine (Internal Medicine), 2004 - 2006- Chicago Medical School/Rosalind Franklin University of Medicine & ScienceResidency, Internal Medicine, 2000 - 2004
Universidad Autonoma de GuadalajaraClass of 1997
Certifications & Licensure
FL State Medical License 2014 - 2026
TX State Medical License 2012 - 2017
KY State Medical License 2009 - 2015
VA State Medical License 2009 - 2014
IL State Medical License 2000 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Member American College Cardiology, 2005
- Member Alpha Omega Alpha, 2004
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Publications & Presentations
PubMed
- 1 citationsPercutaneous closure of an iatrogenic fistula from the left ventricle to the coronary sinus.Zachary M. Gertz, Jose-Luis E. Velazquez-Cecena, J V Nixon
Catheterization and Cardiovascular Interventions. 2015-08-01 - 9 citationsSyncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.Jose-Luis E Velazquez-Cecena, David L. Lubell, Nagapradeep Nagajothi, Hytham Al-Masri, Mumtaz A. Siddiqui
Texas Heart Institute Journal. 2009-01-01 - 23 citationsPioglitazone and the risk of myocardial infarction and other major adverse cardiac events: a meta-analysis of randomized, controlled trials.Nagapradeep Nagajothi, Sasikanth Adigopula, Saravanan Balamuthusamy, Jose-Luis E Velazquez-Cecena, Kalpana Raghunathan
American Journal of Therapeutics. 2008-11-01
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
